China Isotope & Radiation (HKSE:01763) Other Current Payables: HK$4,151 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01763 China Isotope & Radiation Corp HKSE:01763
93 GF Score
Price HK$13.36
GF Value HK$15.46
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is China Isotope & Radiation Other Current Payables?

China Isotope & Radiation HKSE:01763 -0.96% 93 Other Current Payables is HK$4,151 Mil as of Jun. 2026. GuruFocus rates HKSE:01763 with a GF Score™ of 93/100 and a GF Value™ of HK$15.46 (Modestly Undervalued). The stock has 5 warning signs investors should review.

China Isotope & Radiation's Other Current Payables for the quarter that ended in Jun. 2026 was HK$4,151 Mil.

China Isotope & Radiation's quarterly Other Current Payables increased from Jun. 2025 (HK$0 Mil) to Dec. 2025 (HK$2,846 Mil) and increased from Dec. 2025 (HK$2,846 Mil) to Jun. 2026 (HK$4,151 Mil).

China Isotope & Radiation's annual Other Current Payables declined from Dec. 2023 (HK$2,788 Mil) to Dec. 2024 (HK$2,590 Mil) but then increased from Dec. 2024 (HK$2,590 Mil) to Dec. 2025 (HK$2,846 Mil).


China Isotope & Radiation Other Current Payables Related Terms


China Isotope & Radiation Other Current Payables Historical Data

* Premium members only.

The historical data trend for China Isotope & Radiation's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Isotope & Radiation Other Current Payables Chart

China Isotope & Radiation Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 2,850.26 2,787.77 2,590.15 2,845.75

China Isotope & Radiation Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2,590.15 0.00 2,845.75 4,150.77
HKSE:01763
93GF Score
China Isotope & Radiation Corp HKSE:01763
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Isotope & Radiation Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of HK$4,151 Mil mean?
China Isotope & Radiation (HKSE:01763) has a Other Current Payables of HK$4,151 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on China Isotope & Radiation and its competitors.
Is China Isotope & Radiation's Other Current Payables too high?
China Isotope & Radiation's current Other Current Payables is HK$4,151 Mil. Overall, China Isotope & Radiation has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's Other Current Payables compare to ABT and SYK?
China Isotope & Radiation's Other Current Payables of HK$4,151 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on China Isotope & Radiation and its competitors. China Isotope & Radiation's current Other Current Payables is HK$4,151 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
Based on GuruFocus' analysis, China Isotope & Radiation (HKSE:01763) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$15.46, compared to a current price of HK$13.36 — trading 13.6% below its estimated fair value. The current Other Current Payables is HK$4,151 Mil. China Isotope & Radiation's overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For China Isotope & Radiation (HKSE:01763), the current Other Current Payables is HK$4,151 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Isotope & Radiation (HKSE:01763) Overvalued in 2026?

Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be undervalued. The current stock price of HK$13.36 is trading 13.6% below its estimated GF Value™ of HK$15.46. GuruFocus considers China Isotope & Radiation to be Modestly Undervalued.

Key valuation signals for HKSE:01763:

  • Other Current Payables: HK$4,151 Mil
  • GF Value™: HK$15.46 vs. price of HK$13.36 (13.6% below fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the HKSE:01763 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Isotope & Radiation Business Description

Other Exchanges 5IR:Germany
Address No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
93GF Score

Get the complete analysis for HKSE:01763

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$13.36
Price
HK$15.46
GF Value